As the global economy mends, the 2021 growth of Recombinant Erythropoietin Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Recombinant Erythropoietin Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Recombinant Erythropoietin Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Recombinant Erythropoietin Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Recombinant Erythropoietin Drugs market, reaching US$ million by the year 2028. As for the Europe Recombinant Erythropoietin Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Recombinant Erythropoietin Drugs players cover Amgen, Johnson & Johnson, Kyowa Hakko Kirin, and Roche, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Erythropoietin Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
rhEPO
Erythropoiesis-Stimulating Agents (ESA)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Chronic Kidney Disease
Cancer Related Anemia
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Roche
3SBio Group
Celltrion, Inc
Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche Ltd
LG Life Sciences Ltd
Biocon Limited
Intas Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr. Reddy's Laboratories Ltd